Gallagher posts $110m revenue jump for first quarter
Gallagher spent $6.5m in Q1 on Giles and Bollinger integrations.
Arthur J Gallagher has reported revenue of $568.6m (£343.1m) for its broking segment in the first quarter of 2014.
This is compared with $454.4m reported in the same period of 2013.
Integration costs
Acquisition integration costs totalled $6.5m, up from the $3m spent on deals in the first quarter of 2013. Integration costs related to the acquisitions of Giles and Bollinger came in at $4.2m and $2.3m, respectively.
According to Gallagher, these costs were “primarily related to the on-boarding of
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.
You are currently unable to print this content. Please contact info@insuranceage.co.uk to find out more.
You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@insuranceage.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@insuranceage.co.uk
Most read
- ‘Not right’: Biba CEO Trudgill reveals sad letter of small broker crushed by regulation
- Jensten wholesale division split sees MD Simon Taylor exit
- Biba 2024: Aviva not afraid of ‘tough’ conversations, but ‘categorially’ committed to broker PL, says MD Morris